ANTIRENIN IMMUNIZATION VERSUS ANGIOTENSIN CONVERTING ENZYME-INHIBITION IN RATS

被引:20
作者
LO, M
JULIEN, C
MICHEL, JB
VINCENT, M
CERUTTI, C
GOMEZSANCHEZ, CE
SASSARD, J
机构
[1] FAC PHARM LYON,CNRS,URA 606,DEPT PHYSIOL & CLIN PHARMACOL,8 AVE ROCKEFELLER,F-69008 LYONS,FRANCE
[2] INSERM,U36,F-75005 PARIS,FRANCE
[3] UNIV S FLORIDA,COLL MED,DEPT INTERNAL MED,TAMPA,FL 33620
[4] VET ADM MED CTR,TAMPA,FL
关键词
Autonomic nervous system; Baroreceptor reflex; Blood pressure; Catecholamines; Spontaneously hypertensive rat; Steroids;
D O I
10.1161/01.HYP.16.1.80
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The effects of specific active immunization against renin were compared with those of chronic angiotensin converting enzyme (ACE) inhibition. Male spontaneously hypertensive rats (SHR) were immunized (SHR-I) (n=10) against pure murine renin (four injections of 30 μg/kg s.c.) or received (SHR-P) (n=11) a converting enzyme inhibitor (perindopril, 2 mg/kg/day per os for 4 weeks). Sham-immunized SHR (SHR-S) (n=12) and normotensive Wistar-Kyoto (WKY-S) (n=12) rats served as controls. At 15 weeks of age, 24-hour average blood pressure was obtained in freely moving rats using intra-aortic pressure recording with computer analysis. Antirenin immunization induced high circulating titers of antibodies, a fall in plasma renin activity (-95%), and urinary excretion of mineralocorticoids. Perindopril abolished the pressor response to angiotensin I, whereas plasma ACE was only partly (-56%) decreased. It also increased plasma renin activity and did not alter the urinary excretion of steroids. Both immunization and perindopril allowed the blood pressure of SHR to return to the level of WKY-S rats and reduced the left ventricular weight. These decreases were associated with an elevated sympathetic nervous system activity as indicated by increases in the urinary excretion of catecholamines and their metabolites. It is concluded that, apart from an unaltered steroid synthesis, most of the cardiovascular effects of chronic ACE inhibition are similar to those of antirenin immunization, thus indicating that blockade of the circulating and renal renin-angiotensin system accounts for most of the effects of ACE inhibitors.
引用
收藏
页码:80 / 88
页数:9
相关论文
共 44 条
[1]   ANTIHYPERTENSIVE EFFECTS OF S9490-3, A NEW CONVERTING-ENZYME-INHIBITOR, IN THE CONSCIOUS SPONTANEOUSLY HYPERTENSIVE RAT [J].
BARRES, C ;
CERUTTI, C ;
PAULTRE, CZ ;
SASSARD, J .
CLINICAL SCIENCE, 1986, 70 (02) :167-175
[2]   SYMPATHETIC FUNCTION IN SPONTANEOUSLY HYPERTENSIVE RATS AFTER CHRONIC ADMINISTRATION OF CAPTOPRIL [J].
BERECEK, KH ;
KIRK, KA ;
NAGAHAMA, S ;
OPARIL, S .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (04) :H796-H806
[3]   MOLECULAR-CLONING OF RAT RENIN CDNA AND ITS GENE [J].
BURNHAM, CE ;
HAWELUJOHNSON, CL ;
FRANK, BM ;
LYNCH, KR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) :5605-5609
[4]   EFFECT OF A KININ ANTAGONIST ON THE ACUTE ANTIHYPERTENSIVE ACTIVITY OF ENALAPRILAT IN SEVERE HYPERTENSION [J].
CARBONELL, LF ;
CARRETERO, OA ;
STEWART, JM ;
SCICLI, AG .
HYPERTENSION, 1988, 11 (03) :239-243
[5]  
CERUTTI C, 1985, J PHARMACOL METHOD, V13, P249, DOI 10.1016/0160-5402(85)90025-7
[6]   BRAIN ANGIOTENSIN-II AND BARORECEPTOR REFLEX FUNCTION IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
CHENG, SWT ;
KIRK, KA ;
ROBERTSON, JD ;
BERECEK, KH .
HYPERTENSION, 1989, 14 (03) :274-281
[7]   ISOLATION AND CHARACTERIZATION OF RENIN-LIKE ENZYMES FROM MOUSE SUBMAXILLARY-GLANDS [J].
COHEN, S ;
TAYLOR, JM ;
INAGAMI, T ;
MURAKAMI, K ;
MICHELAKIS, AM .
BIOCHEMISTRY, 1972, 11 (23) :4286-+
[8]  
CORVOL P, 1973, FEBS LETT, V34, P180
[9]   COMPARISONS INVITRO, EXVIVO, AND INVIVO OF THE ACTIONS OF 7 STRUCTURALLY DIVERSE INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME (ACE) [J].
CUSHMAN, DW ;
WANG, FL ;
FUNG, WC ;
GROVER, GJ ;
HARVEY, CM ;
SCALESE, RJ ;
MITCH, SL ;
DEFORREST, JM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 :S115-S131
[10]   SPECTROPHOTOMETRIC ASSAY AND PROPERTIES OF ANGIOTENSIN-CONVERTING ENZYME OF RABBIT LUNG [J].
CUSHMAN, DW ;
CHEUNG, HS .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (07) :1637-+